Otolaryngology Doctors in Pueblo, CO Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Dr. Clifford Scott Howe, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1619 N Greenwood St Ste 309, Pueblo, CO 81003 Phone: 719-544-7115    Fax: 719-544-6242

Esperanza F Salazar, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1218 S Pueblo Blvd, Pueblo, CO 81005 Phone: 719-566-1277    Fax: 719-566-1257

Dr. Charlene J Hickson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1218 S Pueblo Blvd, Pueblo, CO 81005 Phone: 719-566-1277    Fax: 719-566-1257

Dr. Julie A Newburg, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1304 N Grand Ave, Pueblo, CO 81003 Phone: 719-544-3752    Fax: 719-542-1794

Dr. Brian Leslie Dodds, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1619 N Greenwood, Suite 309, Pueblo, CO 81003 Phone: 719-544-7115    Fax: 719-544-6242

News Archive

Peninsula Foundation secures funding for PCOS and diabetes research

The Peninsula Foundation, the charitable arm of the Peninsula College of Medicine and Dentistry, has secured funding of -15,000 from The Duchy Health Charity for research into Polycystic Ovary Syndrome (PCOS) and diabetes. The research led, by Professor Jonathan Pinkney at the Knowledge Spa campus in Truro, will be the first non commercial medical research to be carried out at the site.

Researchers develop tiny color-changing sensor molecules

A new approach to building an "artificial nose" using fluorescent compounds and DNA could accelerate the use of sniffing sensors into the realm of mass production and widespread use, say Stanford chemists. If their method lives up to its promise, it could one day detect everything from incipiently souring milk to high explosives.

Researchers use aquaculture to tackle snail fever

Pioneering research led by the University of Stirling could play a vital role in reducing the prevalence of "snail fever" - a debilitating infection that affects more than 200 million people worldwide.

Macuclear and Mystic announce groundbreaking results from Phase Ib Clinical Trial for Macular Degeneration

MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc., announced today preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of Age Related Macular Degeneration (AMD). The preliminary results indicated that MacuCLEAR's MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina.

Read more Medical News

› Verified 5 days ago